BeStock  

Amylyx Pharmaceuticals AMLX

US equityMarket cap rank #2350Drug Manufacturers - Specialty & Generic
$26.02 −$0.18 (-0.69%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $25.55 -1.81%
Open$25.64
Prev close$26.20
Day range$25.52 – $26.40
Volume1.14M
Market cap$3.35B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts9
Average target$46.25+77.7% vs. price
  • Buy 100%
Low $39.00Now $26.02Avg $46.25High $57.00

Recent rating changes

The last 20 actions on file set price targets from $32.00 to $57.00, averaging $45.06.

DateFirmRatingTarget
10 Nov 2026 Mizuho Securities BUY $39.00
5 Nov 2026 Citi BUY $39.00
5 Nov 2026 H.C. Wainwright BUY $55.00
29 Oct 2026 Mizuho Securities BUY $38.00
16 Oct 2026 Citi BUY $39.00
15 Oct 2026 Citi BUY $39.00
1 Oct 2026 Stifel BUY $45.00
26 Aug 2026 Guggenheim BUY $57.00
22 Aug 2026 LifeSci Capital BUY $44.00
20 Aug 2026 H.C. Wainwright BUY $55.00
19 Aug 2026 Mizuho Securities BUY $42.00
19 Aug 2026 H.C. Wainwright BUY $55.00
18 Aug 2026 TD Cowen BUY –
18 Aug 2026 LifeSci Capital BUY $44.00
18 Aug 2026 Mizuho Securities BUY $42.00
18 Aug 2026 BofA Securities BUY $39.00
18 Aug 2026 Baird BUY $52.00
18 Aug 2026 Stifel BUY –
18 Aug 2026 Citi BUY $32.00
18 Aug 2026 Guggenheim BUY $55.00

Discussion

No comments yet — be the first to weigh in on AMLX.

Sign in to join the discussion.

Scroll to Top